Pfizer to halt biosimilar output in China, sell assets to WuXi Biologics

Retrieved on: 2021-03-17 04:07:30

Tags for this article:

Click the tags to see associated articles and topics

Pfizer to halt biosimilar output in China, sell assets to WuXi Biologics. View article details on hiswai:

Excerpt

BEIJING (Reuters) - Pfizer Inc has decided to stop producing biosimilar products in China and sell a unit in the eastern city of Hangzhou to WuXi ...

Article found on: wtvbam.com